NEJM at ESMO - Ponsegromab in Cancer Cachexia No … ← NEJM at ESMO - Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer NEJM at ESMO - Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma →